The U.S. Food and Drug Administration (FDA) is investigating the possible risks of using codeine-containing medicines to treat coughs and colds in children under 18 years because of the potential for serious side effects, including slowed or difficult breathing. They are evaluating all available information and will also consult with external experts by convening an advisory committee to discuss these safety issues. The FDA will communicate final conclusions when their review is complete.
Sign Up For A Free 30-Day Trial of StayAlert >>
